OTCMKTS:MMNFF

MedMen Enterprises Competitors

$0.35
-0.02 (-5.41 %)
(As of 04/12/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.34
Now: $0.35
$0.39
50-Day Range
$0.31
MA: $0.39
$0.51
52-Week Range
$0.10
Now: $0.35
$1.47
Volume1.92 million shs
Average Volume10.96 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

MedMen Enterprises (OTCMKTS:MMNFF) Vs. ABAHF, ACRGF, APPB, AYRSF, CANB, and CNTMF

Should you be buying MMNFF stock or one of its competitors? Companies in the industry of "drug manufacturers - specialty & generic" are considered alternatives and competitors to MedMen Enterprises, including Abacus Health Products (ABAHF), Acreage (ACRGF), Applied Biosciences (APPB), Ayr Strategies (AYRSF), Can B (CANB), and Cansortium (CNTMF).

MedMen Enterprises (OTCMKTS:MMNFF) and Abacus Health Products (OTCMKTS:ABAHF) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, profitability, institutional ownership, risk, analyst recommendations and earnings.

Profitability

This table compares MedMen Enterprises and Abacus Health Products' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
MedMen EnterprisesN/AN/AN/A
Abacus Health ProductsN/AN/AN/A

Earnings & Valuation

This table compares MedMen Enterprises and Abacus Health Products' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MedMen EnterprisesN/AN/AN/AN/AN/A
Abacus Health ProductsN/AN/AN/AN/AN/A

Analyst Recommendations

This is a summary of recent ratings for MedMen Enterprises and Abacus Health Products, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
MedMen Enterprises20001.00
Abacus Health Products0000N/A

Acreage (OTCMKTS:ACRGF) and MedMen Enterprises (OTCMKTS:MMNFF) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, dividends, profitability, analyst recommendations, valuation, earnings and institutional ownership.

Analyst Recommendations

This is a breakdown of current recommendations for Acreage and MedMen Enterprises, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Acreage01202.67
MedMen Enterprises20001.00

Acreage presently has a consensus price target of $8.4333, indicating a potential upside of 204.45%. Given Acreage's stronger consensus rating and higher possible upside, research analysts clearly believe Acreage is more favorable than MedMen Enterprises.

Profitability

This table compares Acreage and MedMen Enterprises' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
AcreageN/AN/AN/A
MedMen EnterprisesN/AN/AN/A

Valuation and Earnings

This table compares Acreage and MedMen Enterprises' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AcreageN/AN/AN/AN/AN/A
MedMen EnterprisesN/AN/AN/AN/AN/A

Summary

Acreage beats MedMen Enterprises on 3 of the 3 factors compared between the two stocks.

Applied Biosciences (OTCMKTS:APPB) and MedMen Enterprises (OTCMKTS:MMNFF) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, analyst recommendations and dividends.

Valuation and Earnings

This table compares Applied Biosciences and MedMen Enterprises' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Applied BiosciencesN/AN/AN/AN/AN/A
MedMen EnterprisesN/AN/AN/AN/AN/A

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Applied Biosciences and MedMen Enterprises, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Applied Biosciences0000N/A
MedMen Enterprises20001.00

Profitability

This table compares Applied Biosciences and MedMen Enterprises' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Applied BiosciencesN/AN/AN/A
MedMen EnterprisesN/AN/AN/A

MedMen Enterprises (OTCMKTS:MMNFF) and Ayr Strategies (OTCMKTS:AYRSF) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, risk, earnings, dividends, analyst recommendations, institutional ownership and profitability.

Profitability

This table compares MedMen Enterprises and Ayr Strategies' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
MedMen EnterprisesN/AN/AN/A
Ayr StrategiesN/AN/AN/A

Analyst Ratings

This is a summary of recent ratings and price targets for MedMen Enterprises and Ayr Strategies, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
MedMen Enterprises20001.00
Ayr Strategies01602.86

Ayr Strategies has a consensus price target of $34.8571, suggesting a potential upside of 63.96%. Given Ayr Strategies' stronger consensus rating and higher probable upside, analysts plainly believe Ayr Strategies is more favorable than MedMen Enterprises.

Earnings & Valuation

This table compares MedMen Enterprises and Ayr Strategies' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MedMen EnterprisesN/AN/AN/AN/AN/A
Ayr StrategiesN/AN/AN/AN/AN/A

Summary

Ayr Strategies beats MedMen Enterprises on 3 of the 3 factors compared between the two stocks.

Can B (NASDAQ:CANB) and MedMen Enterprises (OTCMKTS:MMNFF) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, earnings, profitability, valuation, risk and institutional ownership.

Profitability

This table compares Can B and MedMen Enterprises' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Can BN/AN/AN/A
MedMen EnterprisesN/AN/AN/A

Analyst Ratings

This is a breakdown of current ratings and target prices for Can B and MedMen Enterprises, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Can B0000N/A
MedMen Enterprises20001.00

Valuation and Earnings

This table compares Can B and MedMen Enterprises' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Can BN/AN/AN/AN/AN/A
MedMen EnterprisesN/AN/AN/AN/AN/A

MedMen Enterprises (OTCMKTS:MMNFF) and Cansortium (OTCMKTS:CNTMF) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, profitability, dividends, institutional ownership, valuation, analyst recommendations and earnings.

Profitability

This table compares MedMen Enterprises and Cansortium's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
MedMen EnterprisesN/AN/AN/A
CansortiumN/AN/AN/A

Earnings and Valuation

This table compares MedMen Enterprises and Cansortium's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MedMen EnterprisesN/AN/AN/AN/AN/A
CansortiumN/AN/AN/AN/AN/A

Analyst Ratings

This is a breakdown of recent recommendations and price targets for MedMen Enterprises and Cansortium, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
MedMen Enterprises20001.00
Cansortium00103.00

Cansortium has a consensus target price of $1.20, suggesting a potential upside of 43.13%. Given Cansortium's stronger consensus rating and higher probable upside, analysts clearly believe Cansortium is more favorable than MedMen Enterprises.

Summary

Cansortium beats MedMen Enterprises on 3 of the 3 factors compared between the two stocks.


MedMen Enterprises Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
ABAHF
Abacus Health Products
0.4$4.84-5.4%$0.00N/A0.00Gap Up
Acreage logo
ACRGF
Acreage
1.2$2.77-0.0%$0.00N/A0.00
APPB
Applied Biosciences
0.5$0.25-0.0%$0.00N/A0.00High Trading Volume
Gap Up
AYRSF
Ayr Strategies
1.4$21.26-0.0%$0.00N/A0.00
Can B logo
CANB
Can B
0.4$0.56-1.8%$0.00N/A0.00Gap Up
Cansortium logo
CNTMF
Cansortium
1.1$0.84-1.2%$0.00N/A0.00
Charlotte's Web logo
CWBHF
Charlotte's Web
1.3$4.30-4.9%$0.00N/A0.00
Choom logo
CHOOF
Choom
0.5$0.10-0.0%$0.00N/A0.00Gap Up
CPHRF
Cipher Pharmaceuticals
1.2$1.08-0.0%$0.00N/A0.00
CLS Holdings USA logo
CLSH
CLS Holdings USA
0.7$0.22-0.0%$0.00N/A0.00Gap Down
Cosmos logo
COSM
Cosmos
0.5$5.70-1.8%$0.00N/A0.00Gap Up
Cresco Labs logo
CRLBF
Cresco Labs
1.5$12.48-2.0%$0.00N/A0.00
Curaleaf logo
CURLF
Curaleaf
1.6$14.42-1.9%$0.00N/A0.00
HMDEF
DionyMed Brands
0.5N/AN/A$0.00N/A0.00High Trading Volume
Easton Pharmaceuticals logo
EAPH
Easton Pharmaceuticals
0.5$0.00-0.0%$0.00N/A0.00Gap Down
Elixinol Global logo
ELLXF
Elixinol Global
0.8$0.15-0.0%$0.00N/A0.00Gap Down
EVIO
EVIO
0.6$0.00-0.0%$0.00N/A0.00Gap Down
Flower One logo
FLOOF
Flower One
0.4$0.28-0.0%$0.00N/A0.00Gap Up
Golden Leaf logo
GLDFF
Golden Leaf
0.5$0.05-0.0%$0.00N/A0.00Gap Down
Green Growth Brands logo
GGBXF
Green Growth Brands
0.4$0.01-0.0%$0.00N/A0.00Gap Down
Green Thumb Industries logo
GTBIF
Green Thumb Industries
1.7$28.53-1.5%$0.00N/A0.00Gap Up
GTEC logo
GGTTF
GTEC
0.6$0.61-1.6%$0.00N/A0.00News Coverage
Gap Down
Harvest Health & Recreation logo
HRVSF
Harvest Health & Recreation
1.3$2.92-4.8%$0.00N/A0.00
Hemp Naturals logo
HPMM
Hemp Naturals
0.6$0.01-0.0%$0.00N/A0.00
Hexo logo
HYYDF
Hexo
0.6$5.30-1.8%$0.00N/A0.00
Hikma Pharmaceuticals logo
HKMPY
Hikma Pharmaceuticals
0.4$59.68-0.0%$0.00N/A0.00
iAnthus Capital logo
ITHUF
iAnthus Capital
0.6$0.23-4.4%$0.00N/A0.00Gap Up
Icanic Brands logo
ICNAF
Icanic Brands
0.6$0.34-2.9%$0.00N/A0.00
KNHBF
ICC International Cannabis
0.6N/AN/A$0.00N/A0.00
Invictus MD Strategies logo
IVITF
Invictus MD Strategies
0.6$0.04-27.0%$0.00N/A0.00
Isodiol International logo
ISOLF
Isodiol International
0.4$0.05-44.4%$0.00N/A0.00Gap Down
Khiron Life Sciences logo
KHRNF
Khiron Life Sciences
1.4$0.43-4.7%$0.00N/A0.00
KHTRF
Knight Therapeutics
1.2$4.20-0.5%$0.00N/A0.00
Marijuana Company of America logo
MCOA
Marijuana Company of America
0.5$0.01-0.0%$0.00N/A0.00Gap Up
Medical Marijuana logo
MJNA
Medical Marijuana
0.6$0.05-0.0%$0.00N/A0.00
MediPharm Labs logo
MEDIF
MediPharm Labs
1.2$0.40-5.0%$0.00N/A0.00
MERCK Kommanditgesellschaft auf Aktien logo
MKKGY
MERCK Kommanditgesellschaft auf Aktien
0.5$34.83-1.4%$0.00N/A0.00
MJardin Group logo
MJARF
MJardin Group
0.9$0.08-12.8%$0.00N/A0.00Gap Up
MYHI
Mountain High Acquisitions
0.5$0.03-33.3%$0.00N/A0.00News Coverage
Gap Up
PHCEF
Pharmacielo
0.7$1.44-1.4%$0.00N/A0.00
Plus Products logo
PLPRF
Plus Products
1.1$0.55-3.6%$0.00N/A0.00
Premier Biomedical logo
BIEI
Premier Biomedical
0.5$0.00-4.0%$0.00N/A0.00
PCYN
Procyon
0.4$0.70-0.0%$0.00N/A0.00
Pure Global Cannabis logo
PRCNF
Pure Global Cannabis
0.7$0.01-4.8%$0.00N/A0.00Gap Up
SANP
Santo Mining
0.5$0.01-0.0%$0.00N/A0.00Gap Down
Shionogi & Co., Ltd. logo
SGIOY
Shionogi & Co., Ltd.
0.5$13.18-1.6%$0.00N/A0.00
DNPUF
Sumitomo Dainippon Pharma
0.5$17.40-0.0%$0.00N/A0.00
TerrAscend logo
TRSSF
TerrAscend
1.7$9.80-3.2%$0.00N/A0.00
The Flowr logo
FLWPF
The Flowr
1.5$0.25-4.0%$0.00N/A0.00
The Supreme Cannabis logo
SPRWF
The Supreme Cannabis
1.0$0.31-3.2%$0.00N/A0.00Analyst Downgrade
This page was last updated on 4/12/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.